INS and Hyperinsulinemia: Therapy that leads to hyperinsulinemia, such as sulphonylureas and exogenous insulin, are thought to increase the risk of cancer, while treatment that reduces insulin resistance, such as metformin, are thought to reduce the risk of cancer development.